Peptide ·Emerging evidence ·Reviewed May 2026
Sermorelin is a 29-amino-acid GHRH analog that stimulates pituitary growth hormone release when pituitary reserve is present. It was previously FDA-approved as Geref for pediatric growth hormone deficiency and diagnostic use, but the marketed product was discontinued; current adult anti-aging, body composition, recovery, or wellness use is not FDA-approved and has limited outcome evidence. Use should be clinician-supervised with IGF-1 and metabolic monitoring, and it is not appropriate in active malignancy or uncontrolled endocrine disease.
The bottom line
Evidence rating emerging. Most-documented uses: stimulates endogenous gh release in supervised testing, may raise igf-1 when pituitary reserve is present, previously used for pediatric growth hormone deficiency. 3 sources indexed (1996–2013), with 3 interaction records on file.
Core mechanism
Sermorelin binds growth hormone-releasing hormone receptors on anterior pituitary somatotrophs, increasing cyclic AMP signaling and pulsatile endogenous GH release. GH then increases hepatic and peripheral IGF-1 production, which mediates many growth and metabolic effects. Because sermorelin depends on pituitary responsiveness, it is not equivalent to exogenous growth hormone and will not work in severe pituitary failure.1,2
Peptide is not orally bioavailable in ordinary capsules. Injectable use requires sterile handling and medical oversight.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Compounded sterile injectable.
Costs vary widely by pharmacy and prescription protocol; research products should not be used for human injection. Updated 2026-06-04.
Dose: Clinician-supervised diagnostic protocol only1,2
Timing: Endocrinology protocol
Modern diagnostic pathways vary and may use other agents.
Dose: No FDA-approved dose
Timing: Not applicable
Outcome evidence for longevity, strength, fat loss, or recovery is limited.
What to test, the optimal window inside the conventional range, and how long a response takes.
May increase IGF-1 if pituitary GH reserve is present.1,2
Interpret against age-adjusted reference ranges and clinical context.
GH-axis stimulation can worsen glucose tolerance in susceptible users.
Monitor more closely in prediabetes, diabetes, or metabolic syndrome.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Can stimulate endogenous GH and IGF-1 when pituitary reserve is intact.
Low IGF-1 requires endocrine evaluation, not self-treatment.
GH-axis claims for recovery are biologically plausible but not well proven for healthy adults.
Avoid research-grade peptides for performance goals.
Only relevant if true GH deficiency is diagnosed.1,2
Fatigue has many more common causes.
Both are often used at night and may cause sleepiness or obscure sleep-related adverse effects.
Recommendation: Use only with clinician guidance if sermorelin is prescribed; monitor morning grogginess and sleep quality objectively.
Berberine may lower glucose while GH-axis stimulation may worsen glucose tolerance in susceptible users.
Recommendation: Monitor fasting glucose and A1c; do not use supplement stacking to manage peptide-induced dysglycemia without medical care.
Alpha-lipoic acid may lower glucose while sermorelin-related GH/IGF-1 changes can alter glucose handling.
Recommendation: Use glucose monitoring when combining in insulin-resistant users.
Numbered references. Citations throughout the page link here.
Daily GHRH(1-29) therapy increased growth velocity in children with GH deficiency.
Review summarized sermorelin biology, diagnostic use, and pediatric growth hormone deficiency data.
FDA stated discontinued Geref products were not withdrawn for safety or effectiveness reasons.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
